Idiopathic hypercalciuria and formation of calcium renal stones

Nature Reviews Nephrology

Volumn 12, Issue 9, 2016, Pages 519-533

  Coe, Fredric L ^a   Worcester, Elaine M ^a   Evan, Andrew P ^b  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^b INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APATITE; CALCIUM; CALCIUM OXALATE; CALCIUM PHOSPHATE DIBASIC; CHLORTALIDONE; CITRATE POTASSIUM; CITRIC ACID; HYDROCHLOROTHIAZIDE; HYDROXYAPATITE; INDAPAMIDE; PHOSPHATE; PLACEBO; POTASSIUM; PROTEIN; SODIUM; THIAZIDE DIURETIC AGENT;

BONE DISEASE; BONE MINERAL; CALCIUM ABSORPTION; CALCIUM BALANCE; CALCIUM OXALATE STONE; CALCIUM STONE; CALCIUM URINE LEVEL; CLINICAL TRIAL (TOPIC); CRYSTAL; DIURETIC THERAPY; EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY; FLUID INTAKE; GLOMERULUS BASEMENT MEMBRANE; HUMAN; IDIOPATHIC HYPERCALCIURIA; INTESTINE ABSORPTION; KIDNEY CORTEX; KIDNEY OUTER MEDULLA; KIDNEY TUBULE; KIDNEY TUBULE ABSORPTION; MEDULLARY SPONGE KIDNEY; NEPHROLITHIASIS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN URINE LEVEL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENT DISEASE; REVIEW; RISK FACTOR; RISK REDUCTION; SODIUM RESTRICTION; STONE FORMATION; URIC ACID STONE; URINALYSIS; URINARY EXCRETION; URINE PH; UROLITHIASIS; CHEMISTRY; COMPLICATION; HYPERCALCIURIA; KIDNEY CALCULI; PATHOLOGY;

APATITES; CALCIUM; HUMANS; HYPERCALCIURIA; KIDNEY CALCULI;

EID: 84979567331     PISSN: 17595061     EISSN: 1759507X     Source Type: Journal    
DOI: 10.1038/nrneph.2016.101     Document Type: Review

References (126)

1. Scales, C. D. Jr., Smith, A. C., Hanley, J. M., & Saigal, C. S. Prevalence of kidney stones in the United States. Eur. Urol. 62, 160-165 (2012).
2. Kirkali, Z., Rasooly, R., Star, R. A., & Rodgers, G. P. Urinary stone disease: progress, status, and needs. Urology 86, 651-653 (2015).
3. Worcester, E. M., & Coe, F. L. Nephrolithiasis. Prim. Care 35, 369-391 (2008).
4. Worcester, E. M., & Coe, F. L. New insights into the pathogenesis of idiopathic hypercalciuria. Semin. Nephrol. 28, 120-132 (2008).
5. Parks, J. H., Worcester, E. M., Coe, F. L., Evan, A. P., & Lingeman, J. E. Clinical implications of abundant calcium phosphate in routinely analyzed kidney stones. Kidney Int. 66, 777-785 (2004).
6. Evan, A. P., et al. Mechanisms of human kidney stone formation. Urolithiasis. 43 (Suppl. 1), 19-32 (2015).
7. Miller, N. L., et al. A formal test of the hypothesis that idiopathic calcium oxalate stones grow on Randall's plaque. BJU Int. 103, 966-971 (2009).
8. Miller, N. L., et al. In idiopathic calcium oxalate stone-formers, unattached stones show evidence of having originated as attached stones on Randall's plaque. BJU Int. 105, 242-245 (2010).
9. Linnes, M. P., et al. Phenotypic characterization of kidney stone formers by endoscopic and histological quantification of intrarenal calcification. Kidney Int. 84, 818-825 (2013).
10. Wang, X., et al. Distinguishing characteristics of idiopathic calcium oxalate kidney stone formers with low amounts of Randall's plaque. Clin. J. Am. Soc. Nephrol. 9, 1757-1763 (2014).
11. Viers, B. R., et al. Endoscopic and histologic findings in a cohort of uric acid and calcium oxalate stone formers. Urology 85, 771-776 (2015).
12. Letavernier, E., et al. Demographics and characterization of 10,282 Randall plaque-related kidney stones: a new epidemic?. Medicine (Baltimore) 94, e566 (2015).
13. Evan, A. E., et al. Histopathology and surgical anatomy of patients with primary hyperparathyroidism and calcium phosphate stones. Kidney Int. 74, 223-229 (2008).
14. Evan, A. P., et al. Intra-tubular deposits, urine and stone composition are divergent in patients with ileostomy. Kidney Int. 76, 1081-1088 (2009).
15. Evan, A. P., et al. Renal histopathology and crystal deposits in patients with small bowel resection and calcium oxalate stone disease. Kidney Int. 78, 310-317 (2010).
16. Evan, A. P., et al. Contrasting histopathology and crystal deposits in kidneys of idiopathic stone formers who produce hydroxy apatite, brushite, or calcium oxalate stones. Anat. Rec. (Hoboken) 297, 731-748 (2014).
17. Evan, A. P., et al. Crystal-associated nephropathy in patients with brushite nephrolithiasis. Kidney Int. 67, 576-591 (2005).
18. Coe, F. L., Evan, A. P., Lingeman, J. E., & Worcester, E. M. Plaque and deposits in nine human stone diseases. Urol. Res. 38, 239-247 (2010).
19. Evan, A. P., et al. Randall's plaque of patients with nephrolithiasis begins in basement membranes of thin loops of Henle. J. Clin. Invest. 111, 607-616 (2003).
20. Evan, A. P., et al. Apatite plaque particles in inner medulla of kidneys of calcium oxalate stone formers: osteopontin localization. Kidney Int. 68, 145-154 (2005).
21. Evan, A. P., et al. Renal inter-α-trypsin inhibitor heavy chain 3 increases in calcium oxalate stone-forming patients. Kidney Int. 72, 1503-1511 (2007).
22. Williams, J. C., et al. Micro CT imaging of Randall's plaques. Urolithiasis 43 (Suppl. 1), 13-17 (2015).
23. Khan, S. R., Rodriguez, D. E., Gower, L. B., & Monga, M. Association of Randall plaque with collagen fibers and membrane vesicles. J. Urol. 187, 1094-1100 (2012).
24. Evan, A. P., et al. Biopsy proven medullary sponge kidney: clinical findings, histopathology, and role of osteogenesis in stone and plaque formation. Anat. Rec. (Hoboken) 298, 865-877 (2015).
25. Kuo, R. L., et al. Urine calcium and volume predict coverage of renal papilla by Randall's plaque. Kidney Int. 64, 2150-2154 (2003).
26. Kriz, W., & Kaissling, B. in Structural Organization of the Mammalian Kidney in Seldin and Giebisch's The Kidney: Physiology and Pathophysiology eds Alpern, R. J., et al.) 595-691 (Elsevier, 2013).
27. Bernardo, J. F., & Friedman, P. A. in Renal calcium metabolism in Seldin and Giebisch's The Kidney: Physiology and Pathophysiology
28. Coe, F. L., Evan, A., & Worcester, E. Pathophysiology-based treatment of idiopathic calcium kidney stones. Clin. J. Am. Soc. Nephrol. 6, 2083-2092 (2011).
29. Stoller, M. L., Shami, G. S., McCormick, V. D., & Kerschmann, R. L. High resolution radiography of cadaveric kidneys: unraveling the mystery of Randall's plaque formation. J. Urol. 156, 1263-1266 (1996).
30. Alexander, R. T., et al. Kidney stones and cardiovascular events: a cohort study. Clin. J. Am. Soc. Nephrol. 9, 506-512 (2014).
31. Ferraro, P. M., et al. History of kidney stones and the risk of coronary heart disease. JAMA 310, 408-415 (2013).
32. Evan, A. P., et al. Comparison of the pathology of interstitial plaque in human ICSF stone patients to NHERF 1 and THP-null mice. Urol. Res. 38, 439-452 (2010).
33. Evan, A. P., et al. Mechanism of formation of human calcium oxalate renal stones on Randall's plaque. Anat. Rec. (Hoboken.) 290, 1315-1323 (2007).
34. Evan, A. P., et al. Renal intratubular crystals and hyaluronan staining occur in stone formers with bypass surgery but not with idiopathic calcium oxalate stones. Anat. Rec. (Hoboken.) 291, 325-334 (2008).
35. Evan, A. P., et al. Renal histopathology of stone-forming patients with distal renal tubular acidosis. Kidney Int. 71, 795-801 (2007).
36. Evan, A. P., et al. Renal crystal deposits and histopathology in patients with cystine stones. Kidney Int. 69, 2227-2235 (2006).
37. Worcester, E. M., et al. A test of the hypothesis that oxalate secretion produces proximal tubule crystallization in primary hyperoxaluria type I. Am. J. Physiol. Renal Physiol. 305, F1574-F1584 (2013).
38. Worcester, E. M., Parks, J. H., Evan, A. P., & Coe, F. L. Renal function in patients with nephrolithiasis. J. Urol. 176, 600-603 (2006).
39. Coe, F. L., Evan, A. P., Worcester, E. M., & Lingeman, J. E. Three pathways for human kidney stone formation. Urol. Res. 38, 147-160 (2010).
40. Rule, A. D., Krambeck, A. E., & Lieske, J. C. Chronic kidney disease in kidney stone formers. Clin. J. Am. Soc. Nephrol. 6, 2069-2075 (2011).
41. Coe, F. L., & Parks, J. H. in Physical Chemistry of Calcium Stone Disease in Nephrolithiasis: Pathogenesis and Treatment eds Coe, F. L., & Parks, J. H.) 38-58 (Year Book Medical Publishers, 1988).
42. Qiu, S. R., & Orme, C. A. Dynamics of biomineral formation at the near-molecular level. Chem. Rev. 108, 4784-4822 (2008).
43. Finlayson, B. in Calcium stones: some physical and clinical aspects in Calcium metabolism in renal failure and nephrolithiasis eds David, D. S.) 337-382 (John Wiley & Sons, 1977).
44. Parks, J. H., Coward, W. M., & Coe, F. L. Correspondence between stone composition and urine supersaturation in nephrolithiasis. Kidney Int. 51, 894-900 (1997).
45. Bergsland, K. J., Zisman, A. L., Asplin, J. R., Worcester, E. M., & Coe, F. L. Evidence for net renal tubule oxalate secretion in patients with calcium kidney stones. Am. J. Physiol. Renal Physiol. 300, F311-F318 (2011).
46. Santucci, L., et al. Urinary proteome in a snapshot: normal urine and glomerulonephritis. J. Nephrol. 26, 610-616 (2013).
47. Wright, C. A., et al. Label-free quantitative proteomics reveals differentially regulated proteins influencing urolithiasis. Mol. Cell. Proteomics 10, M110 (2011).
48. Kumar, V., & Lieske, J. C. Protein regulation of intrarenal crystallization. Curr. Opin. Nephrol. Hypertens. 15, 374-380 (2006).
49. Aggarwal, K. P., Narula, S., Kakkar, M., & Tandon, C. Nephrolithiasis: molecular mechanism of renal stone formation and the critical role played by modulators. Biomed. Res. Int. 2013, 292953 (2013).
50. Canales, B. K., et al. Proteome of human calcium kidney stones. Urology 76, 1017-1020 (2010).
51. Pak, C. Y. C. Physicochemical basis for formation of renal stones of calcium phosphate origin: calculation of the degree of supersaturation of urine with respect to brushite. J. Clin. Invest. 48, 1914-1922 (1969).
52. Nancollas, G. H., & Henneman, Z. J. Calcium oxalate: calcium phosphate transformations. Urol. Res. 38, 277-280 (2010).
53. Costa-Bauza, A., et al. Type of renal calculi: variation with age and sex. World J. Urol. 25, 415-421 (2007).
54. Joseph, N. R. The dissociation constants of organic calcium complexes. J. Biol. Chem. 164, 529-541 (1946).
55. Rodgers, A. L., Allie-Hamdulay, S., Jackson, G. E., & Sutton, R. A. Enteric hyperoxaluria secondary to small bowel resection: use of computer simulation to characterize urinary risk factors for stone formation and assess potential treatment protocols. J. Endourol. 28, 985-994 (2014).
56. De Yoreo, J. J., Qiu, S. R., & Hoyer, J. R. Molecular modulation of calcium oxalate crystallization. Am. J. Physiol. Renal Physiol. 291, F1123-F1131 (2006).
57. Coe, F. L., Parks, J. H., & Moore, E. S. Familial idiopathic hypercalciuria. N. Engl. J. Med. 300, 337-340 (1979).
58. Albright, F., Henneman, P., Benedict, P. H., & Forbes, A. P. Idiopathic hypercalciuria: a preliminary report. Proc. R. Soc. Med. 46, 1077-1081 (1953).
59. Heilberg, I. P., & Weisinger, J. R. Bone disease in idiopathic hypercalciuria. Curr. Opin. Nephrol. Hypertens. 15, 394-402 (2006).
60. Curhan, G. C., & Taylor, E. N. 24 h uric acid excretion and the risk of kidney stones. Kidney Int. 73, 489-496 (2008).
61. Blaine, J., Chonchol, M., & Levi, M. Renal control of calcium, phosphate, and magnesium homeostasis. Clin. J. Am. Soc. Nephrol. 10, 1257-1272 (2015).
62. Liberman, U. A., et al. Metabolic and calcium kinetic studies in idiopathic hypercalciuria. J. Clin. Invest. 47, 2580-2590 (1968).
63. Heaney, R. P., & Skillman, T. G. Secretion and excretion of calcium by the human gastrointestinal tract. J. Lab. Clin. Med. 64, 29-41 (1964).
64. Nassim, J. R., & Higgins, B. A. Control of idiopathic hypercalciuria. Br. Med. J. 1, 675-681 (1965).
65. Edwards, N. A., & Hodgekinson, A. Metabolic studies in patients with idiopathic hypercalciuria. Clin. Sci. 29, 143-157 (1965).
66. Henneman, P. H., Benedict, P. H., Forbes, A. P., & Dudley, H. R. Idiopathic hypercalciuria. N. Engl. J. Med. 259, 802-807 (1958).
67. Jackson, W. P. U., & Dancaster, C. A consideration of the hypercalciuria in sarcoidosis, idiopathic hypercalciuria, and that produced by vitamin D. A new suggestion regarding calcium metabolism. J. Clin. Endocrinol. Metab. 19, 658 (1959).
68. Harrison, A. R. Some results of metabolic investigations in cases of renal stone. Br. J. Urol. 31, 398 (1959).
69. Dent, C. E., Harper, C. M., & Parfitt, A. M. The effect of cellulose phosphate on calcium metabolism in patients with hypercalciuria. Clin. Sci. 27, 417-425 (1964).
70. Parfitt, A. M., Higgins, B. A., Nassim, J. R., Collins, J. A., & Hilb, A. Metabolic studies in patients with hypercalciuria. Clin. Sci. 27, 463-482 (1964).
71. Yendt, E. R., Gagne, R. J. A., & Cohanim, M. The effects of thiazides in idiopathic hypercalciuria. Trans. Am. Clin. Climatol. Assoc. 77, 96-110 (1966).
72. Dent, C. E., & Watson, L. Metabolic studies in a patient with idiopathic hypercalciuria. Br. Med. J. 2, 449-452 (1965).
73. Anderson, J., Lee, H. A., & Tomlinson, R. W. Some metabolic aspects of idiopathic hypercalciuria. Nephron 4, 129-138 (1967).
74. Khanal, R. C., & Nemere, I. Regulation of intestinal calcium transport. Annu. Rev. Nutr. 28, 179-196 (2008).
75. Insogna, K. L., Broadus, A. E., Dreyer, B. E., Ellison, A. F., & Gertner, J. M. Elevated production rate of 1,25 dihydroxyvitamin D in patients with absorptive hypercalciuria. J. Clin. Endocrinol. Metab. 61, 490-495 (1985).
76. Bushinsky, D. A., Frick, K. K., & Nehrke, K. Genetic hypercalciuric stone-forming rats. Curr. Opin. Nephrol. Hypertens. 15, 403-418 (2006).
77. Worcester, E. M., et al. Evidence that postprandial reduction of renal calcium reabsorption mediates hypercalciuria of patients with calcium nephrolithiasis. Am. J. Physiol. Renal Physiol. 292, F66-F75 (2007).
78. Worcester, E. M., Bergsland, K. J., Gillen, D. L., & Coe, F. L. Evidence for increased renal tubule and parathyroid gland sensitivity to serum calcium in human idiopathic hypercalciuria. Am. J. Physiol. Renal Physiol. 305, F853-F860 (2013).
79. Worcester, E. M., et al. Evidence for increased postprandial distal nephron calcium delivery in hypercalciuric stone-forming patients. Am. J. Physiol. Renal Physiol. 295, F1286-F1294 (2008).
80. Coe, F. L., et al. Effects of low-calcium diet on urine calcium excretion, parathyroid function and serum 1,25(OH)2D3 levels in patients with idiopathic hypercalciuria and in normal subjects. Am. J. Med. 72, 25-32 (1982).
81. Qaseem, A., Dallas, P., Forciea, M. A., Starkey, M., & Denberg, T. D. Dietary and pharmacologic management to prevent recurrent nephrolithiasis in adults: a clinical practice guideline from the American College of Physicians. Ann. Intern. Med. 161, 659-667 (2014).
82. Bergsland, K. J., Coe, F. L., Gillen, D. L., & Worcester, E. M. A test of the hypothesis that the collecting duct calcium-sensing receptor limits rise of urine calcium molarity in hypercalciuric calcium kidney stone formers. Am. J. Physiol. Renal Physiol. 297, F1017-F1023 (2009).
83. Pak, C. Y. C., Sakhaee, K., Crowther, C., & Brinkley, L. Evidence justifying a high fluid intake in treatment of nephrolithiaisis. Ann. Intern. Med. 93, 36-39 (1980).
84. Borghi, L., et al. Urinary volume, water and recurrences of idiopathic calcium nephrolithiasis: a 5 year randomized prospective study. J. Urol. 155, 839-843 (1996).
85. Breslau, N. A., Mcguire, J. L., Zerwekh, J. E., & Pak, C. Y. C. The role of dietary sodium on renal excretion and intstinal absorption of calicum and on vitamin D metabolism. J. Clin. Endocrinol. Metab. 55, 369-373 (1982).
86. Sakhaee, K., Harvey, J. A., Padalino, P., Whitson, P., & Pak, C. Y. C. The potential role of salt abuse on the risk for kidney stone formation. J. Urol. 150, 310-312 (1993).
87. McCarron, D. A., et al. Urinary calcium excretion at extremes of sodium intake in normal man. Am. J. Nephrol. 1, 84-90 (1981).
88. Phillips, M. J., & Cooke, J. N. C. Relation between urinary calcium and sodium in patients with idiopathic hypercalciuria. Lancet 1, 1354-1357 (1967).
89. Teucher, B., et al. Sodium and bone health: impact of moderately high and low salt intakes on calcium metabolism in postmenopausal women. J. Bone Miner. Res. 23, 1477-1485 (2008).
90. McParland, B. E., Goulding, A., & Campbell, A. J. Dietary salt affects biochemical markers of resorption and formation of bone in elderly women. BMJ 299, 834-835 (1989).
91. Frings-Meuthen, P., Baecker, N., & Heer, M. Low-grade metabolic acidosis may be the cause of sodium chloride-induced exaggerated bone resorption. J. Bone Miner. Res. 23, 517-524 (2008).
92. Nascimento, L., Oliveros, F. H., & Cunningham, E. Renal handling of sodium and calcium in hypercalciuria. Clin. Pharmacol. Ther. 35, 342-347 (1984).
93. Pak, C. Y., et al. Effect of dietary modification on urinary stone risk factors. Kidney Int. 68, 2264-2273 (2005).
94. Muldowney, F. P., Freaney, R., & K.Moloney, M. F. Importance of dietary sodium in the hypercalciuria syndrome. Kidney Int. 22, 292-296 (1982).
95. Silver, J., Rubinger, D., Friedlaender, M. M., & Popovtzer, M. M. Sodium-dependent idiopathic hypercalciuria in renal-stone formers. Lancet 2, 484-486 (1983).
96. Nouvenne, A., et al. Diet to reduce mild hyperoxaluria in patients with idiopathic calcium oxalate stone formation: a pilot study. Urology 73, 725-730.e1 (2009).
97. Nouvenne, A., et al. Effects of a low-salt diet on idiopathic hypercalciuria in calcium-oxalate stone formers: a 3 mo randomized controlled trial. Am. J. Clin. Nutr. 91, 565-570 (2010).
98. Burtis, W. J., Gay, L., Insogna, K. L., Ellison, A., & Broadus, A. E. Dietary hypercalciuria in patients with calcium oxalate kidney stones. Am. J. Clin. Nutr. 60, 424-429 (1994).
99. Blackwood, A. M., Sagnella, G. A., Cook, D. G., & Cappuccio, F. P. Urinary calcium excretion, sodium intake and blood pressure in a multi-ethnic population: results of the Wandsworth Heart and Stroke Study. J. Hum. Hypertens. 15, 229-237 (2001).
100. Taylor, E. N., & Curhan, G. C. Demographic, dietary, and urinary factors and 24 h urinary calcium excretion. Clin. J. Am. Soc. Nephrol. 4, 1980-1987 (2009).
101. Damasio, P. C., et al. The role of salt abuse on risk for hypercalciuria. Nutr. J. 10, 3 (2011).
102. Borghi, L., et al. Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N. Engl. J. Med. 346, 77-84 (2002).
103. Yendt, E. R., Gagne, R. J. A., & Cohanim, M. The effects of thiazides in idiopathic hypercalciuria. Am. J. Med. Sci. 261, 449-460 (1966).
104. Fink, H. A., et al. Medical management to prevent recurrent nephrolithiasis in adults: a systematic review for an American College of Physicians Clinical Guideline. Ann. Intern. Med. 158, 535-543 (2013).
105. Laerum, E., & Larsen, S. Thiazide prophylaxis of urolithiasis: a double-blind study in general practice. Acta Med. Scand. 215, 383-389 (1984).
106. Ettinger, B., Citron, J. T., Livermore, B., & Dolman, L. I. Chlorthalidone reduces calcium oxalate calculous recurrence but magnesium hydroxide does not. J. Urol. 139, 679-684 (1988).
107. Borghi, L., Meschi, T., Guerra, A., & Novarini, A. Randomized prospective study of a nonthiazide diuretic, indapamide, in preventing calcium stone recurrences. J. Cardiovasc. Pharmacol. 22, S78-S86 (1993).
108. Bergsland, K. J., Worcester, E. M., & Coe, F. L. Role of proximal tubule in the hypocalciuric response to thiazide of patients with idiopathic hypercalciuria. Am. J. Physiol. Renal Physiol. 305, F592-F599 (2013).
109. Coe, F. L., Parks, J. H., Bushinsky, D. A., Langman, C. B., & Favus, M. J. Chlorthalidone promotes mineral retention in patients with idiopathic hypercalciuria. Kidney Int. 33, 1140-1146 (1988).
110. Bolland, M. J., et al. The effect of treatment with a thiazide diuretic for 4 years on bone density in normal postmenopausal women. Osteoporos. Int. 18, 479-486 (2007).
111. Aung, K., & Htay, T. Thiazide diuretics and the risk of hip fracture. Cochrane Database Syst. Rev. 10, CD005185 (2011).
112. Caudarella, R., Vescini, F., Buffa, A., & Stefoni, S. Citrate and mineral metabolism: kidney stones and bone disease. Front. Biosci. 8, s1084-s1106 (2003).
113. Curthoys, N. P., & Moe, O. W. Proximal tubule function and response to acidosis. Clin. J. Am. Soc. Nephrol. 9, 1627-1638 (2014).
114. Halperin, M. L., Cheema, D. S., & Kamel, K. S. Physiology of acid-base balance: links with kidney stone prevention. Semin. Nephrol. 26, 441-446 (2006).
115. Pinheiro, V. B., Baxmann, A. C., Tiselius, H. G., & Heilberg, I. P. The effect of sodium bicarbonate upon urinary citrate excretion in calcium stone formers. Urology 82, 33-37 (2013).
116. Moseley, K. F., Weaver, C. M., Appel, L., Sebastian, A., & Sellmeyer, D. E. Potassium citrate supplementation results in sustained improvement in calcium balance in older men and women. J. Bone Miner. Res. 28, 497-504 (2013).
117. Menegon, L. F., Figueiredo, J. F., & Gontijo, J. A. Effect of metabolic acidosis on renal tubular sodium handling in rats as determined by lithium clearance. Braz. J. Med. Biol. Res. 31, 1269-1273 (1998).
118. Safirstein, R., Glassman, V. P., & DiScala, V. A. Effects of an NH4Cl induced metabolic acidosis on salt and water reabsorption in dog kidney. Am. J. Physiol. 225, 805-809 (1973).
119. Wang, T., Egbert, A. L. Jr., Aronson, P. S., & Giebisch, G. Effect of metabolic acidosis on NaCl transport in the proximal tubule. Am. J. Physiol. 274, F1015-F1019 (1998).
120. Balkovetz, D. F., Chumley, P., & Amlal, H. Downregulation of claudin 2 expression in renal epithelial cells by metabolic acidosis. Am. J. Physiol. Renal Physiol. 297, F604-F611 (2009).
121. Barcelo, P., Wuhl, O., Servitge, E., Rousaud, A., & Pak, C. Y. C. Randomized double-blind study of potassium citrate in idiopathic hypocitraturic calcium nephrolithiasis. J. Urol. 150, 1761-1764 (1993).
122. Ettinger, B., et al. Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis. J. Urol. 158, 2069-2073 (1997).
123. Hofbauer, J., Hobarth, K., Szabo, N., & Marberger, M. Alkali citrate prophylaxis in idiopathic recurrent calcium oxalate urolithiasis - a prospective randomized study. Br. J. Urol. 73, 362-365 (1994).
124. Soygur, T., Akbay, A., & Kupeli, S. Effect of potassium citrate therapy on stone recurrence and residual fragments after shockwave lithotripsy in lower caliceal calcium oxalate urolithiasis: a randomized controlled trial. J. Endourol. 16, 149-152 (2002).
125. Lojanapiwat, B., et al. Alkaline citrate reduces stone recurrence and regrowth after shockwave lithotripsy and percutaneous nephrolithotomy. Int. Braz. J. Urol. 37, 611-616 (2011).
126. Johnsson, M. S., & Nancollas, G. H. The role of brushite and octacalcium phosphate in apatite formation. Crit. Rev. Oral Biol. Med. 3, 61-82 (1992).